Cargando…

Evaluating dose response from flexible dose clinical trials

BACKGROUND: The true dose effect in flexible-dose clinical trials may be obscured and even reversed because dose and outcome are related. METHODS: To evaluate dose effect in response on primary efficacy scales from 2 randomized, double-blind, flexible-dose trials of patients with bipolar mania who r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lipkovich, Ilya, Adams, David H, Mallinckrodt, Craig, Faries, Doug, Baron, David, Houston, John P
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2254403/ https://www.ncbi.nlm.nih.gov/pubmed/18179713 http://dx.doi.org/10.1186/1471-244X-8-3

Ejemplares similares

Identifying patterns in treatment response profiles in acute bipolar mania: a cluster analysis approach
por: Lipkovich, Ilya A, et al.
Publicado: (2008)

Neuropathic pain responds better to increased doses of pregabalin: an in-depth analysis of flexible-dose clinical trials
por: Serpell, Michael, et al.
Publicado: (2017)

The efficacy of duloxetine: A comprehensive summary of results from MMRM and LOCF_ANCOVA in eight clinical trials
por: Mallinckrodt, Craig H, et al.
Publicado: (2004)

The impact of analytic method on interpretation of outcomes in longitudinal clinical trials
por: Prakash, A, et al.
Publicado: (2008)

Flexible use of copula‐type model for dose‐finding in drug combination clinical trials
por: Hashizume, Koichi, et al.
Publicado: (2021)

Safety and Efficacy of Flexible-Dose Deutetrabenazine in Children and Adolescents With Tourette Syndrome: A Randomized Clinical Trial
por: Jankovic, Joseph, et al.
Publicado: (2021)

A flexible dose-response modeling framework based on continuous toxicity outcomes in phase I cancer clinical trials
por: Lee, Se Yoon
Publicado: (2023)

Application of structured statistical analyses to identify a biomarker predictive of enhanced tralokinumab efficacy in phase III clinical trials for severe, uncontrolled asthma
por: Gottlow, Mattis, et al.
Publicado: (2019)

Thromboprophylaxis with standard-dose vs. flexible-dose heparin for hospitalized COVID-19 patients: a target trial emulation
por: Martínez-Alés, Gonzalo, et al.
Publicado: (2022)

Dose-Response of Paraxanthine on Cognitive Function: A Double Blind, Placebo Controlled, Crossover Trial
por: Xing, Dante, et al.
Publicado: (2021)

Implementation of ICH E9 (R1): A Few Points Learned During the COVID-19 Pandemic
por: Qu, Yongming, et al.
Publicado: (2021)

An Exposure-Response Perspective on the Clinical Dose of Pretomanid
por: Nedelman, Jerry R., et al.
Publicado: (2020)

Dosing study of massage for chronic neck pain: protocol for the dose response evaluation and analysis of massage [DREAM] trial
por: Sherman, Karen J, et al.
Publicado: (2012)

Is acupuncture dose dependent? Ramifications of acupuncture treatment dose within clinical practice and trials
por: Bauer, Matthew, et al.
Publicado: (2020)

Development and Evaluation of a Reconstitutable Dry Suspension Containing Isoniazid for Flexible Pediatric Dosing
por: Adeleke, Oluwatoyin A., et al.
Publicado: (2020)

Evaluating the relationship between clinical and demographic characteristics of insulin-using people with diabetes and their health outcomes: a cluster analysis application
por: Eby, Elizabeth L., et al.
Publicado: (2021)

Dose/exposure–response modeling in dose titration trials: Overcoming the titration paradox
por: Kristensen, Niels Rode, et al.
Publicado: (2022)

Response to: Effect of dose reductions on clinical outcomes, or of outcomes on dose reductions?
por: Ismail, R.K., et al.
Publicado: (2022)

Dose Titration Algorithm Tuning (DTAT) should supersede ‘the’ Maximum Tolerated Dose (MTD) in oncology dose-finding trials
por: Norris, David C.
Publicado: (2017)

WHOSE DOSE IS IT ANYWAY? INDIVIDUAL PATIENT DOSE-RESPONSE CURVES FROM THE REMOTE-CARE PERSONAL-COVIDBP TRIAL
por: Taylor, Mike, et al.
Publicado: (2022)

Early evaluation of patient risk for substantial weight gain during olanzapine treatment for schizophrenia, schizophreniform, or schizoaffective disorder
por: Lipkovich, Ilya, et al.
Publicado: (2008)

An open-label, flexible dose adaptive study evaluating the efficacy of vortioxetine in subjects with panic disorder
por: Shah, Anish, et al.
Publicado: (2018)

Flexible dosing with Darbepoetin alfa for the treatment of chemotherapy-induced anemia
por: Wauters, Isabelle, et al.
Publicado: (2006)

Flexible, rule-based dose escalation: The cohort-sequence design
por: Li, Shuang, et al.
Publicado: (2020)

The Effectiveness of Low-dose Dexmedetomidine Infusion in Sedative Flexible Bronchoscopy: A Retrospective Analysis
por: Wu, Sheng Hua, et al.
Publicado: (2020)

Randomized Open Investigation Determining Steroid Dose in Severe COVID-19: The ROIDS-Dose Clinical Trial
por: Rabascall, Carlos X, et al.
Publicado: (2022)

Duloxetine for the long-term treatment of Major Depressive Disorder in patients aged 65 and older: an open-label study
por: Wohlreich, Madelaine M, et al.
Publicado: (2004)

Evaluating dose of cisplatin responsible for causing nephrotoxicity
por: Higuchi, Kyouko, et al.
Publicado: (2019)

A Case of Acute Rheumatism Treated with Full Doses of Quinine
por: Houston, W. M.
Publicado: (1853)

Testing multiple dose combinations in clinical trials
por: Saha, Saswati, et al.
Publicado: (2019)

Effects of dose change on the success of clinical trials
por: Shan, Guogen, et al.
Publicado: (2022)

The safety and efficacy of dexmedetomidine-remifentanil in children undergoing flexible bronchoscopy: A retrospective dose-finding trial
por: Li, Xia, et al.
Publicado: (2017)

Receiver Operating Characteristic Analysis and Clinical Trial Simulation to Inform Dose Titration Decisions
por: Clements, John David, et al.
Publicado: (2018)

Clinical trial simulation to evaluate tenofovir disoproxil fumarate/emtricitabine HIV pre-exposure prophylaxis dosing during pregnancy
por: Scott, Rachel K., et al.
Publicado: (2023)

Evaluation of dose‐dependent treatment effects after mid‐trial dose escalation in biomarker, clinical, and cognitive outcomes for gantenerumab or solanezumab in dominantly inherited Alzheimer's disease
por: Wang, Guoqiao, et al.
Publicado: (2022)

Duloxetine in the treatment of Major Depressive Disorder: A comparison of efficacy in patients with and without melancholic features
por: Mallinckrodt, Craig H, et al.
Publicado: (2005)

Customized flexible hollow microneedles for psoriasis treatment with reduced‐dose drug
por: Ren, Yingjie, et al.
Publicado: (2023)

Dose response of ACE inhibitors: implications of the SECURE trial
por: Lonn, Eva
Publicado: (2001)

Effects of the dose of erythropoiesis stimulating agents on cardiovascular events, quality of life, and health-related costs in hemodialysis patients: the clinical evaluation of the dose of erythropoietins (C.E. DOSE) trial protocol
por: Strippoli, Giovanni FM
Publicado: (2010)

Low-Dose vs Standard-Dose Alteplase in Acute Lacunar Ischemic Stroke: The ENCHANTED Trial
por: Zhou, Zien, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_urfgqi9j90rs98b1qgp4919pur